cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vaxart Inc
103 own
36 watching
Current Price
$0.82
$-0.01
(-0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
122.04M
52-Week High
52-Week High
1.54000
52-Week Low
52-Week Low
0.53000
Average Volume
Average Volume
0.88M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization122.04M
icon52-Week High1.54000
icon52-Week Low0.53000
iconAverage Volume0.88M
iconDividend Yield--
iconP/E Ratio--
What does the Vaxart Inc do?
Aviragen Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of direct-acting antivirals to treat infections worldwide. Its product candidates include vapendavir, which is in Phase IIb SPIRITUS trial for an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor, which is in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections; and BTA074, an antiviral treatment that is in Phase II development for condyloma caused by human papillomavirus types 6 and 11. Aviragen Therapeutics, Inc. has collaboration agreement with Daiichi-Sankyo for the development of Laninamivir octanoate, a neuraminidase inhibitor, which has completed Phase II clinical trial for the treatment of influenza. The company was formerly known as Biota Pharmaceuticals, Inc. and changed its name to Aviragen Therapeutics, Inc. in April 2016. Aviragen Therapeutics, Inc. is based in Alpharetta, Georgia.
Read More
How much money does Vaxart Inc make?
News & Events about Vaxart Inc.
Globe Newswire
1 year ago
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT)today announced it will provide a business update and report financial results for the first quarter ended March 31, 2023 after the market close on Thursday, May 4, ...
Globe Newswire
1 year ago
Company to provide a detailed overview of its norovirus clinical program Webcast to be held on March 28, 2023 at 1:00 p.m. ET SOUTH SAN FRANCISCO, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will host a key opinion leader video webcast on the health and ...
Globe Newswire
1 year ago
Study to evaluate safety and immunogenicity of oral norovirus vaccine in healthy adults SOUTH SAN FRANCISCO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that it has dosed the first subject in the Phase 2 clinical trial of its oral tablet bivalent norovirus ...
Globe Newswire
1 year ago
Mr. Lee brings almost 15 years of experience in strategy, M&A and partnering on more than $20 billion in transactions SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc.(NASDAQ: VXRT) announced today that it has appointed Phillip Lee as its Chief Financial Officer (CFO), ...
Globe Newswire
1 year ago
Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast milk antibodies and transfer of antibodies to young infants SOUTH SAN FRANCISCO, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ...
Frequently Asked Questions
Frequently Asked Questions
What is Vaxart Inc share price today?
plus_minus_icon
Can Indians buy Vaxart Inc shares?
plus_minus_icon
How can I buy Vaxart Inc shares from India?
plus_minus_icon
Can Fractional shares of Vaxart Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vaxart Inc stocks?
plus_minus_icon
What is today’s traded volume of Vaxart Inc?
plus_minus_icon
What is today’s market capitalisation of Vaxart Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vaxart Inc?
plus_minus_icon
What percentage is Vaxart Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vaxart Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.82
$-0.01
(-0.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00